Poillet-Perez, Laura
Xie, Xiaoqi
Zhan, Le
Yang, Yang
Sharp, Daniel W.
Hu, Zhixian Sherrie
Su, Xiaoyang
Maganti, Anurag
Jiang, Cherry
Lu, Wenyun
Zheng, Haiyan
Bosenberg, Marcus W.
Mehnert, Janice M.
Guo, Jessie Yanxiang
Lattime, Edmund
Rabinowitz, Joshua D.
White, Eileen
Article History
Received: 3 May 2018
Accepted: 17 September 2018
First Online: 14 November 2018
Change Date: 6 December 2018
Change Type: Correction
Change Details: In this Letter, ‘released’ should have been ‘regulated’ in the sentence starting: ‘Deletion of <i>Atg5</i> in the host similarly regulated circulating arginine and suppressed tumorigenesis...’ This has been corrected online.
Competing interests
: E.W. is co-founder of Vescor Therapeutics. The other authors declare no competing interests.